Skip to main content
. 2022 Nov 23;13:1023919. doi: 10.3389/fendo.2022.1023919

Table 1.

Baseline characteristics for all individuals and by Lp(a) percentile category.

Variables All individuals Lp (a) Percentiles P for trend
[0, 25] [25, 50) [50, 75) [75, 90) [90, 95) [95, 100]
N 25343 (100) 6327 (25.0) 6336 (25.0) 6343 (25.0) 3800 (15.0) 1267 (5.0) 1268 (5.0)
Lp (a), mg/dl 18.85 ± 20.47 3.53 ± 1.40 8.68 ± 1.73 16.90 ± 3.36 31.76 ± 5.57 50.77 ± 4.83 85.32 ± 23.24 <0.001
Scr, μmol/l 64.27 ± 16.37 62.83 ± 13.96 64.05 ± 14.21 65.09 ± 14.67 65.05 ± 14.45 65.76 ± 14.79 64.59 ± 14.42 <0.001
eGFR, ml/min/1.73 m2 105.09 ± 32.17 107.70 ± 16.24 105.15 ± 16.11 104.09 ± 16.39 103.78 ± 16.49 103.47 ± 16.13 102.41 ± 16.57 <0.001
eGFR under 90, ml/min/1.73 m2 4012 (15.8) 776 (12.3) 970 (15.3) 1093 (17.3) 688 (18.1) 226 (17.8) 259 (20.4) <0.001
eGFR under 60, ml/min/1.73 m2 152(0.6) 23 (0.4) 29 (0.5) 51 (0.8) 24 (0.6) 11 (0.9) 14 (1.1) 0.001
BUN, mmol/l 5.05 ± 1.67 5.00 ± 1.61 5.07 ± 2.07 5.07 ± 1.41 5.05 ± 1.39 5.05 ± 1.47 5.21 ± 1.81 0.004
UA, umol/l 321.90 ± 90.75 321.38 ± 90.98 321.62 ± 91.69 323.19 ± 91.01 322.55 ± 89.20 324.07 ± 89.14 315.48 ± 89.71 0.9016
CRPHS, mg/l 1.91 ± 2.69 1.79 ± 2.40 1.90 ± 2.72 1.99 ± 2.86 1.91 ± 2.73 1.95 ± 2.80 2.00 ± 2.80 0.154
Age, years 50.69 ± 14.44 50.11 ± 13.84 50.75 (14.39) 50.72 ± 14.61 51.11 ± 14.86 50.56 ± 14.77 51.90 ± 15.05 <0.001
Female sex 13774 (54.4) 3255 (51.4) 3472 (54.8) 3468 (54.7) 2099 (55.2) 696 (54.9) 784 (61.9) <0.001
Area, urban 19962 (78.8) 4639 (73.4) 5003 (79.0) 5107 (80.5) 3100 (81.5) 1060 (83.6) 1053 (83.1) <0.001
Education
primary 2838 (11.2) 767 (12.1) 759 (12.0) 695 (11.0) 384 (10.1) 105 (8.3) 128 (10.1) <0.001
secondary 7953 (31.4) 2267 (35.8) 2043 (32.2) 1822 (28.7) 1108 (29.1) 354 (27.9) 359 (28.3)
senior 6042 (23.8) 1612 (25.5) 1504 (23.7) 1502 (23.7) 877 (23.1) 282 (22.3) 265 (20.9)
undergraduate 8510 (33.6) 1681 (26.6) 2030 (32.0) 2324 (36.6) 1433 (37.7) 526 (41.5) 516 (40.7)
Physical activity
Low 18883 (74.5) 4771 (75.4) 4643 (73.3) 4710 (74.3) 2829 (74.4) 977 (77.1) 953 (75.2) 0.136
Intermediate 5541 (21.9) 1294 (20.5) 1460 (23.0) 1421 (22.4) 836 (22.0) 255 (20.1) 275 (21.7)
High 919 (3.6) 262 (4.1) 233 (3.7) 212 (3.3) 137 (3.6) 36 (2.8) 39 (3.1)
Exercise
5-7 d/w 11455 (45.2) 2750 (43.5) 2897 (45.7) 2908 (45.8) 1702 (44.8) 596 (47.0) 602 (47.5) <0.001
1-4 d/w 8512 (33.6) 2036 (32.2) 2121 (33.5) 2133 (33.6) 1345 (35.4) 422 (33.3) 454 (35.9)
<1 d/w 5376 (21.2) 1541 (24.4) 1318 (20.8) 1302 (20.5) 755 (19.9) 250 (19.7) 210 (16.6)
Current smoking 6038 (23.8) 1753 (27.7) 1492 (23.6) 1484 (23.4) 822 (21.6) 281 (22.2) 206 (16.3) <0.001
Alcohol taking 9268 (36.6) 2535 (40.1) 2253 (35.6) 2296 (36.2) 1329 (35.0) 453 (35.8) 402 (31.7) <0.001
BMI, kg/m2 25.36 ± 3.64 25.69 ± 3.67 25.42 ± 3.58 25.19 ± 3.53 25.14 ± 3.52 24.92 ± 3.42 24.80 ± 3.36 <0.001
FPG, mmol/L 5.84 ± 1.61 5.86 ± 1.76 5.80 ± 1.51 5.83 ± 1.58 5.85 ± 1.60 5.86 ± 1.53 5.92 ± 1.67 <0.001
TG, mmol/L 1.60 ± 1.07 1.81 ± 1.36 1.61 ± 1.02 1.51 ± 0.92 1.47 ± 0.89 1.48 ± 0.95 1.49 ± 0.84 <0.001
TC, mmol/L 5.12 ± 1.04 4.93 ± 1.03 5.07 ± 1.01 5.17 ± 1.03 5.24 ± 1.04 5.28 ± 1.03 5.49 ± 1.06 <0.001
HDL-C, mmol/L 1.36 ± 0.36 1.31 ± 0.37 1.35 ± 0.35 1.38 ± 0.35 1.39 ± 0.35 1.41 ± 0.35 1.44 ± 0.37 <0.001
LDL-C, mmol/L 3.02 ± 0.86 2.81 ± 0.87 3.00 ± 0.82 3.09 ± 0.85 3.15 ± 0.85 3.18 ± 0.85 3.34 ± 0.88 <0.001
Hypertension 6978 (27.5) 1927 (30.5) 1715 (27.1) 1686 (26.6) 1002 (26.4) 314 (24.8) 334 (26.4) <0.001
Diabetes mellitus 2725 (10.8) 787 (12.4) 669 (10.6) 642 (10.1) 372 (9.8) 122 (9.6) 133 (10.5) 0.003
CVD (CHD+Stroke) 1949(7.7) 483 (7.6) 457 (7.2) 494 (7.8) 285 (7.5) 108 (8.5) 122 (9.6) <0.001

Data are n (%) for categorical variables or mean ± SD for continuous variables.

Scr, serum creatinine; eGFR, estimated glomerular filtration rate; BUN, blood urea nitrogen; UA, uric acid; CRPSH, high-sensitivity C-reactive protein; BMI, body mass index; FPG, fasting blood plasma glucose; TG, Triglycerides; TC, Total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease; CHD, coronary heart disease.